These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15865061)

  • 21. The structures of prostaglandin endoperoxide H synthases-1 and -2.
    Garavito RM; Malkowski MG; DeWitt DL
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():129-52. PubMed ID: 12432914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First and second generations of COX-2 selective inhibitors.
    de Leval X; Julémont F; Benoit V; Frederich M; Pirotte B; Dogné JM
    Mini Rev Med Chem; 2004 Aug; 4(6):597-601. PubMed ID: 15279593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
    Atkinson HG
    Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic advances with coxibs: few certainties and a lot of doubts].
    Jouzeau JY; Daouphars M; Netter P
    Therapie; 2004; 59(2):207-11. PubMed ID: 15359614
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database.
    Zhao SZ; Reynolds MW; Lejkowith J; Whelton A; Arellano FM
    Clin Ther; 2001 Sep; 23(9):1478-91. PubMed ID: 11589261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [COX-2 inhibitor non-steroidal anti-inflammatory drugs, myth or reality?].
    Peretz A
    Rev Med Brux; 2001 Sep; 22(4):A377-80. PubMed ID: 11680204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-based QSAR study on differential inhibition of human prostaglandin endoperoxide H synthase-2 (COX-2) by nonsteroidal anti-inflammatory drugs.
    Pouplana R; Lozano JJ; Pérez C; Ruiz J
    J Comput Aided Mol Des; 2002 Oct; 16(10):683-709. PubMed ID: 12650588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.
    Kurumbail RG; Stevens AM; Gierse JK; McDonald JJ; Stegeman RA; Pak JY; Gildehaus D; Miyashiro JM; Penning TD; Seibert K; Isakson PC; Stallings WC
    Nature; 1996 Dec 19-26; 384(6610):644-8. PubMed ID: 8967954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cyclooxygenase-2 structure: new drugs for an old target?
    Garavito RM
    Nat Struct Biol; 1996 Nov; 3(11):897-901. PubMed ID: 8901861
    [No Abstract]   [Full Text] [Related]  

  • 30. Kinetic basis for selective inhibition of cyclo-oxygenases.
    Gierse JK; Koboldt CM; Walker MC; Seibert K; Isakson PC
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):607-14. PubMed ID: 10215599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural approach for COX-2 inhibition.
    Michaux C; Charlier C
    Mini Rev Med Chem; 2004 Aug; 4(6):603-15. PubMed ID: 15279594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
    Hochberg MC
    Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isomeric acetoxy analogues of rofecoxib: a novel class of highly potent and selective cyclooxygenase-2 inhibitors.
    Rahim MA; Rao PN; Knaus EE
    Bioorg Med Chem Lett; 2002 Oct; 12(19):2753-6. PubMed ID: 12217369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cyclooxygenase isoforms: structural insights into the conversion of arachidonic acid to prostaglandins.
    Garavito RM; DeWitt DL
    Biochim Biophys Acta; 1999 Nov; 1441(2-3):278-87. PubMed ID: 10570255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemometric rationalization of the structural and physicochemical basis for selective cyclooxygenase-2 inhibition: toward more specific ligands.
    Filipponi E; Cecchetti V; Tabarrini O; Bonelli D; Fravolini A
    J Comput Aided Mol Des; 2000 Mar; 14(3):277-91. PubMed ID: 10756482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4-substituted 1,5-diarylpyrazole, analogues of celecoxib: synthesis and preliminary evaluation of biological properties.
    Menozzi G; Merello L; Fossa P; Mosti L; Piana A; Mattioli F
    Farmaco; 2003 Sep; 58(9):795-808. PubMed ID: 13679172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tracing the origins of COX-2 inhibitors' structures.
    Lednicer D
    Curr Med Chem; 2002 Aug; 9(15):1457-61. PubMed ID: 12173976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electronic-topological study of structurally diverse cyclooxygenase-2 inhibitors.
    Dimoglo A; Sim E; Shvets N; Ahsen V
    Mini Rev Med Chem; 2003 Jun; 3(4):281-94. PubMed ID: 12678822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COX-2 inhibitors.
    Brooks PM; Day RO
    Med J Aust; 2000 Oct; 173(8):433-6. PubMed ID: 11090038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage.
    Tanaka A; Hase S; Miyazawa T; Takeuchi K
    J Pharmacol Exp Ther; 2002 Mar; 300(3):754-61. PubMed ID: 11861778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.